Search Results

You are looking at 1 - 10 of 204 items for :

  • "head and neck cancer" x
  • All content x
Clear All
Full access

David G. Pfister, Sharon Spencer, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, Frank Dunphy, David W. Eisele, Jill Gilbert, Maura L. Gillison, Robert I. Haddad, Bruce H. Haughey, Wesley L. Hicks Jr, Ying J. Hitchcock, Antonio Jimeno, Merrill S. Kies, William M. Lydiatt, Ellie Maghami, Renato Martins, Thomas McCaffrey, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, Cristina P. Rodriguez, Sandeep Samant, David E. Schuller, Jatin P. Shah, Randal S. Weber, Gregory T. Wolf, Frank Worden, Sue S. Yom, Nicole R. McMillian, and Miranda Hughes

% rule (omitting clinical scenarios that comprise less than 5% of all cases) was used to eliminate uncommon clinical occurrences or conditions from these NCCN Guidelines. NNCCN Clinical Practice Guidelines in Oncology : Head and Neck Cancers

Full access

David G. Pfister, Kie-Kian Ang, David M. Brizel, Barbara A. Burtness, Anthony J. Cmelak, A. Dimitrios Colevas, Frank Dunphy, David W. Eisele, Jill Gilbert, Maura L. Gillison, Robert I. Haddad, Bruce H. Haughey, Wesley L. Hicks Jr., Ying J. Hitchcock, Merrill S. Kies, William M. Lydiatt, Ellie Maghami, Renato Martins, Thomas McCaffrey, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, Sandeep Samant, Giuseppe Sanguineti, David E. Schuller, Jatin P. Shah, Sharon Spencer, Andy Trotti III, Randal S. Weber, Gregory T. Wolf, and Frank Worden

NCCN Clinical Practice Guidelines in Oncology for Head and Neck Cancers NCCN Categories of Evidence and Consensus Category 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) and there is uniform

Full access

Natalie Riblet, Karen Skalla, Auden McClure, Karen Homa, Alison Luciano, and Thomas H. Davis

Symptoms of psychological distress, such as depression and anxiety, are common with any cancer but are particularly prevalent with head and neck cancers (HNCs), affecting as many as 35% of patients. 1 , 2 Several factors likely contribute to risk

Full access

David G. Pfister, Kie-Kian Ang, David M. Brizel, Barbara A. Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, Frank Dunphy, David W. Eisele, Jill Gilbert, Maura L. Gillison, Robert I. Haddad, Bruce H. Haughey, Wesley L. Hicks Jr, Ying J. Hitchcock, Merrill S. Kies, William M. Lydiatt, Ellie Maghami, Renato Martins, Thomas McCaffrey, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, Sandeep Samant, David E. Schuller, Jatin P. Shah, Sharon Spencer, Randal S. Weber, Gregory T. Wolf, Frank Worden, Sue S. Yom, Nicole R. McMillian, and Miranda Hughes

: Integrate into professional practice the updates to NCCN Guidelines for Head and Neck Cancers Describe the rational behind the decision-making process for developing the NCCN Guidelines for Head and Neck Cancers NCCN Categories of Evidence and

Full access

Presenters: Jimmy J. Caudell, David G. Pfister, and Randal S. Weber

Although a broad spectrum of quality-of-life issues impact patients with head and neck cancers (HNC), a few are paramount: receiving inadequate nutrition and having dental complications after radiation therapy. In a panel moderated by David G

Full access

David Adelstein, Maura L. Gillison, David G. Pfister, Sharon Spencer, Douglas Adkins, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Moon Fenton, Robert L. Foote, Jill Gilbert, Robert I. Haddad, Wesley L. Hicks Jr, Ying J. Hitchcock, Antonio Jimeno, Debra Leizman, William M. Lydiatt, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, James Rocco, Cristina P. Rodriguez, Jatin P. Shah, Randal S. Weber, Matthew Witek, Frank Worden, Sue S. Yom, Weining Zhen, Jennifer L. Burns, and Susan D. Darlow

Cancers Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Head and Neck Cancers NCCN Guidelines Insights : Head and Neck Cancers, Version 2.2017 Version 2.2017 © National Comprehensive Cancer

Full access

David G. Pfister, Sharon Spencer, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, A. Dimitrios Colevas, Frank Dunphy, David W. Eisele, Robert L. Foote, Jill Gilbert, Maura L. Gillison, Robert I. Haddad, Bruce H. Haughey, Wesley L. Hicks Jr, Ying J. Hitchcock, Antonio Jimeno, Merrill S. Kies, William M. Lydiatt, Ellie Maghami, Thomas McCaffrey, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, Cristina P. Rodriguez, Sandeep Samant, Jatin P. Shah, Randal S. Weber, Gregory T. Wolf, Frank Worden, Sue S. Yom, Nicole McMillian, and Miranda Hughes

be able to: Integrate into professional practice the updates to the NCCN Guidelines for Head and Neck Cancers Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Head and Neck Cancers NCCN

Full access

Benjamin R. Roman, Snehal G. Patel, Marilene B. Wang, Anna M. Pou, F. Christopher Holsinger, David Myssiorek, David Goldenberg, Samuel Swisher-McClure, Alexander Lin, Jatin P. Shah, and Judy A. Shea

-being, and because false-positives may lead to unnecessary procedures, treatment, and radiation exposure. 6 Despite these recommendations, use of surveillance imaging is common in oncology, 7 – 11 including in head and neck cancers. 12 However, physician

Full access

A. Dimitrios Colevas, Sue S. Yom, David G. Pfister, Sharon Spencer, David Adelstein, Douglas Adkins, David M. Brizel, Barbara Burtness, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, David W. Eisele, Moon Fenton, Robert L. Foote, Jill Gilbert, Maura L. Gillison, Robert I. Haddad, Wesley L. Hicks Jr, Ying J. Hitchcock, Antonio Jimeno, Debra Leizman, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, John A. Ridge, James Rocco, Cristina P. Rodriguez, Jatin P. Shah, Randal S. Weber, Matthew Witek, Frank Worden, Weining Zhen, Jennifer L. Burns, and Susan D. Darlow

10, 2018; Expiration date: May 10, 2019 Learning Objectives: Upon completion of this activity, participants will be able to: Integrate into professional practice the updates to the NCCN Guidelines for Head and Neck Cancers Describe the rationale

Full access

Duke Comprehensive Cancer Center

Oral cavity, pharyngeal, and laryngeal cancers account for about 3% of new cancer cases in the United States. Alcohol and tobacco abuse are common etiologic factors in some of these cancers. Moreover, because the entire aerodigestive tract epithelium may be exposed to these carcinogens, patients with head and neck cancer are at risk for developing second primary neoplasms. Stage at diagnosis is the most predictive factor of survival. Important new updates to the NCCN guidelines for 2008 include the addition of chemo/radiation therapy as an option in adjuvant treatment for several head and neck cancers and the addition of human papilloma virus testing to the workup. This version of the guidelines is limited to tumors arising in the oral cavity, oropharynx, hypopharynx, nasopharynx, and glottic and supraglottic larynx. The complete version can be found on the NCCN Web site at www.nccn.org

For the most recent version of the guidelines, please visit NCCN.org